Mayo Clinic - AuthorCitation

Efficacy of Erenumab for the Treatment of Patients With Chronic Migraine With and Without Aura (S32.006)

Kudrow, David, Tepper, Stewart J. , Cheng, Sunfa , Leonardi, Dean, Lenz, Robert , Mikol, Daniel D., Ashina, Messoud , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s32.006

Erenumab Safety Among Migraine Patients Using Triptans or With Cardiovascular (CV) Risk Factors (P4.100)

Winner, Paul, Kudrow, David, Rózniecki, J, Xue, Fei , Zhang, Feng, Cheng, Sunfa , Picard, Hernàn , Mikol, Daniel D., Reuter, Uwe , Dodick, David W. , Zhang, Feng

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p4.100

Conversion from Chronic Migraine (CM) to Episodic Migraine (EM) With Long-Term Erenumab Treatment (S17.008)

Tepper, Stewart J. , Silberstein, Stephen D., Kudrow, David, Cheng, Sunfa , Rippon, Gregory A., Zhang, Feng, Mikol, Daniel D., Lipton, Richard B. , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.s17.008

Long-term Efficacy of Erenumab in Patients With Episodic Migraine Who Have Failed Prior Preventive Migraine Therapies (P1.10-020)

Kudrow, David, Klatt, Jan , Picard, Hernàn , Chou, Denise E. , Mikol, Daniel D., Reuter, Uwe , Schwedt, Todd J. , Paemeleire, Koen , Zhang, Feng

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p1.10-020

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002)

Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.s26.002

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001)

Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i3.001

Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study (2328)

Silberstein, Stephen D., Zhang, Feng, Xue, Fei , Cheng, Sunfa , Chou, Denise E. , Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng, Lima, Gabriel Paiva da Silva

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.2328

Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO) (870)

Tepper, Stewart J. , Silberstein, Stephen D., Kudrow, David, Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Lipton, Richard B. , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.870

Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+ Year Results of a 5-year, Open-label Treatment Period (1203)

Silberstein, Stephen D., Xue, Fei , Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1203

Long-term Safety and Tolerability of Erenumab In Episodic Migraine: A Pooled Analysis From Two Clinical Trials and Their Extension Phases (P3-2.005)

Ritter, Shannon, Stites, Tracy , Lima, Gabriel Paiva da Silva , Arkuszewski, Michał , Lima, Gabriel Paiva da Silva , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng , Goadsby, Peter J.

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.324

Reuter, Uwe

Citations 19

Efficacy of Erenumab for the Treatment of Patients With Chronic Migraine With and Without Aura (S32.006)

Kudrow, David, Tepper, Stewart J. , Cheng, Sunfa , Leonardi, Dean, Lenz, Robert , Mikol, Daniel D., Ashina, Messoud , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe

Erenumab Safety Among Migraine Patients Using Triptans or With Cardiovascular (CV) Risk Factors (P4.100)

Winner, Paul, Kudrow, David, Rózniecki, J, Xue, Fei , Zhang, Feng, Cheng, Sunfa , Picard, Hernàn , Mikol, Daniel D., Reuter, Uwe , Dodick, David W. , Zhang, Feng

Conversion from Chronic Migraine (CM) to Episodic Migraine (EM) With Long-Term Erenumab Treatment (S17.008)

Tepper, Stewart J. , Silberstein, Stephen D., Kudrow, David, Cheng, Sunfa , Rippon, Gregory A., Zhang, Feng, Mikol, Daniel D., Lipton, Richard B. , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Long-term Efficacy of Erenumab in Patients With Episodic Migraine Who Have Failed Prior Preventive Migraine Therapies (P1.10-020)

Kudrow, David, Klatt, Jan , Picard, Hernàn , Chou, Denise E. , Mikol, Daniel D., Reuter, Uwe , Schwedt, Todd J. , Paemeleire, Koen , Zhang, Feng

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002)

Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001)

Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng

Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study (2328)

Silberstein, Stephen D., Zhang, Feng, Xue, Fei , Cheng, Sunfa , Chou, Denise E. , Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng, Lima, Gabriel Paiva da Silva

Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO) (870)

Tepper, Stewart J. , Silberstein, Stephen D., Kudrow, David, Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Lipton, Richard B. , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+ Year Results of a 5-year, Open-label Treatment Period (1203)

Silberstein, Stephen D., Xue, Fei , Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Long-term Safety and Tolerability of Erenumab In Episodic Migraine: A Pooled Analysis From Two Clinical Trials and Their Extension Phases (P3-2.005)

Ritter, Shannon, Stites, Tracy , Lima, Gabriel Paiva da Silva , Arkuszewski, Michał , Lima, Gabriel Paiva da Silva , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng , Goadsby, Peter J.